Aveanna Healthcare (NASDAQ:AVAH) Shares Break Below Fifty Day Moving Average - What's Next?

Key Points

• Aveanna shares fell below their 50-day moving average, trading as low as $12.15 and last at $12.24, versus a 50-day average of $13.06.
• Third-quarter results beat analyst estimates: adjusted earnings were $0.23 per share versus $0.21 expected, and revenue was $695.54 million versus $679.48 million. The company also reported asset impairment charges.
• Analysts’ consensus rating is “Moderate Buy”, with an average price target of $14.25; management has also identified hospice as a priority for potential acquisitions.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) crossed below its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $13.06 and traded as low as $12.15. Aveanna Healthcare shares last traded at $12.24, with a volume of 4,737,247 shares changing hands.

Key Stories Impacting Aveanna Healthcare

Investors following AVAH have been watching these stories:

• Positive Sentiment: Third-quarter adjusted earnings were $0.23 per share, above the $0.21 analyst consensus and up from $0.15 a year earlier. Revenue of $695.54 million also beat estimates of $679.48 million. Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 Guidance
• Neutral Sentiment: Management identified hospice as a priority for mergers and acquisitions. Potential deals could support expansion, though their eventual impact will depend on terms and execution. Hospice an M&A Priority for Aveanna
• Negative Sentiment: Aveanna reported impairment charges involving goodwill, intangible assets and other long-lived assets for the quarter. The write-downs may weigh on reported results and raise questions about the value of those assets, offsetting some of the earnings optimism. Aveanna Reports Asset Impairment for the Third Quarter

Analysts Set New Price Targets

Several research firms have recently weighed in on AVAH. Raymond James Financial reiterated a "strong-buy" rating on shares of Aveanna Healthcare in a research report on Thursday. Barclays upped their price target on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the company an "overweight" rating in a research report on Friday, August 28th. Truist Financial increased their price target on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a "hold" rating in a report on Monday, August 24th. Weiss Ratings raised Aveanna Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, October 14th. Finally, Wall Street Zen lowered Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 15th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $14.25.

Aveanna Healthcare Stock Performance

The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. The stock has a market cap of $2.67 billion, a price-to-earnings ratio of 9.95, a P/E/G ratio of 0.80 and a beta of 2.03. The company's fifty day simple moving average is $13.06 and its two-hundred day simple moving average is $9.44.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last announced its quarterly earnings results on Thursday, November 12th. The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.02. The business had revenue of $695.54 million for the quarter, compared to analysts' expectations of $679.48 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. On average, analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.77 earnings per share for the current year.

Insider Transactions at Aveanna Healthcare

In other news, insider Edwin Reisz sold 50,000 shares of the firm's stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $575,000.00. Following the transaction, the insider owned 1,397,897 shares in the company, valued at $16,075,815.50. This trade represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of Aveanna Healthcare stock in a transaction on Friday, August 21st. The stock was sold at an average price of $11.50, for a total transaction of $25,875,000.00. Following the transaction, the insider directly owned 12,315,892 shares in the company, valued at $141,632,758. This represents a 15.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 48,566,081 shares of company stock valued at $558,509,932. Corporate insiders own 5.30% of the company's stock.

Institutional Trading of Aveanna Healthcare

Several hedge funds have recently added to or reduced their stakes in AVAH. First Trust Advisors LP lifted its stake in Aveanna Healthcare by 110.3% in the third quarter. First Trust Advisors LP now owns 1,401,516 shares of the company's stock valued at $17,393,000 after purchasing an additional 735,090 shares during the last quarter. Boston Partners boosted its position in shares of Aveanna Healthcare by 5.4% in the third quarter. Boston Partners now owns 3,024,899 shares of the company's stock valued at $37,450,000 after acquiring an additional 153,920 shares during the period. Virtus Advisers LLC boosted its holdings in Aveanna Healthcare by 90.9% in the 3rd quarter. Virtus Advisers LLC now owns 80,907 shares of the company's stock valued at $1,004,000 after purchasing an additional 38,517 shares during the period. Diversified Trust Co grew its position in Aveanna Healthcare by 3.6% during the third quarter. Diversified Trust Co now owns 30,932 shares of the company's stock worth $384,000 after buying an additional 1,077 shares in the last quarter. Finally, Pictet Asset Management Holding SA bought a new position in shares of Aveanna Healthcare in the third quarter worth approximately $215,000. Institutional investors own 87.96% of the company's stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc. is a U.S. provider of home-based healthcare services for children and adults with complex medical needs. Its services include private-duty nursing and personal care, home health nursing and therapy, and hospice care, helping patients receive support in their homes and communities. The company also provides medical supplies and related services, including products used for enteral nutrition. Aveanna serves patients and families across multiple states through a network of clinicians, caregivers, and local operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.